Chad Shear is a Principal in Fish & Richardson’s Southern California office, a leader in the firm’s life sciences and pharmaceutical litigation group, and co-chair of the firm’s post grant group. Mr. Shear has extensive experience in Hatch-Waxman and life sciences litigation representing branded clients in litigation relating to GSK (COREG®, FLOVENT®), Gilead (SOVALDI®, HARVONI®, EPCLUSA®, RANEXA®); Allergan (ALPHAGAN® P, .15 and .1, COMBIGAN®, LUMIGAN®, ACUVAIL®, ACULAR® LS and SANCTURA® XR); and iCeutica and Iroko (ZORVOLEX® and VIVLODEX®).
Also included in his extensive client list is Coherus BioSciences, who he’s represented at the US PTO and the US Supreme Court.
Clients describe him as “practical,” “pragmatic” and a “go-to guy for complex patent matters.”
Mr. Shear has participated in more than a dozen trials, domestically and internationally, both as lead trial counsel and as a member of the trial team in the US, UK, Canada, Australia, and Norway. As lead trial counsel, Mr. Shear successfully defended Callaway Golf in a jury trial in the Eastern District of Texas.
Mr. Shear also has experience in Patent Office proceedings, both in the US and in Europe including EPO Opposition Proceedings, US Patent Office Post Grant proceedings and interferences.
In addition to his courtroom work, Mr. Shear teaches life sciences trial and patent practice courses around the country.
September 14, 2018
Fish & Richardson Principals Chad Shear and Jonathan Singer Named “2018 Winning Litigators” by The National Law Journal
July 26, 2018
Fish & Richardson, WilmerHale Secure Total Victory for Gilead Sciences in IPR Trials
May 24, 2018
Fish & Richardson Principal Chad Shear Named to SD Metro’s 2018 Best Attorneys List
May 31st, 2018 | 1:00 pm EDT
Webinar: Hatch-Waxman 301
January 25th, 2018 | 1:00 pm EST
Webinar: Hatch-Waxman 201
December 6th, 2017 | 1:00 pm EST
Webinar: Hatch-Waxman 101
October 13, 2017
11 Fish & Richardson Principals Named 2017 "Life Sciences Stars" by LMG Life Sciences
October 13th, 2016 | 1:00 pm EDT
Webinar: Biologics Litigation and IPRs
April 16th, 2015 | 8:00 am EDT
Patent Resources Group (PRG) Hatch-Waxman and Biosimilars: A Total Immersion Course Encompassing Strategies for Prosecution, FDA Regulation, Post-Grant Challenge, Litigation and Appeal
April 16th, 2015
Hatch-Waxman and Biosimilars: A Total Immersion Course Encompassing Strategies for Prosecution, FDA Regulation, Post-Grant Challenge, Litigation and Appeal
November 10th, 2010
Duty of Disclosure in Reexamination Proceedings
March 30th, 2014
Patent Resources Group PRG course: Pharma & Biotech Strategies for Patent Prosecution, Hatch-Waxman and Litigation